跳至主要内容
临床试验/KCT0002356
KCT0002356已完成未知

A multicenter, non-interventional observational study to evaluate 1-year clinical outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous coronary interventions (PCI) and Prasugrel therapy.

Daiichi-Sankyo Korea0 个研究点目标入组 3,213 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3,213

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19?(Year) 至 75?(Year)(—)
性别
All

入选标准

  • 1) over 19 year
  • 2) Acute coronary syndrome-Percutaneous Coronary Intervention patients treated with prasugrel according to the labeled indication
  • 3) Patients who initiate or switch to prasugrel within 6 months after Percutaneous Coronary Intervention
  • 4) Patients who gie voluntary written informed consent to participate in the study

排除标准

  • 1) Patients who are not simultaneously participating in interventional study administering of antiplatelet agents except prasugrel/antithrombotic agents

研究者

发起方
Daiichi-Sankyo Korea

相似试验